Conference Coverage EuroPCR 2024 See All Content See past conferences Paris, France May 14, 2024 May 17, 2024 News Conference News EuroPCR 2024 Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT It’s not quite a stent and not quite a scaffold—either way, the device was associated with low rates of TLF over follow-up. More News News Conference News EuroPCR 2024 Temporary Pacemaker After TAVI May Preclude Long-term Pacing Caitlin E. Cox May 24, 2024 News Conference News EuroPCR 2024 POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival Yael L. Maxwell May 22, 2024 News Conference News EuroPCR 2024 FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI Caitlin E. Cox May 20, 2024 News Conference News EuroPCR 2024 PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3 Yael L. Maxwell May 17, 2024 News Conference News EuroPCR 2024 OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO Caitlin E. Cox May 16, 2024 More Slides Presentation EuroPCR 2024 Small aortic annuli patients treated with TAVI: outcomes in women in the SMART trial Presenter: Roxana Mehran May 14, 2024 Presentation EuroPCR 2024 One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II Presenter: Ling Tao May 15, 2024 Presentation EuroPCR 2024 First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2 Presenter: Ole De Backer May 15, 2024 Presentation EuroPCR 2024 Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis Presenter: Frederik Zimmermann May 15, 2024 Presentation EuroPCR 2024 Hybrid coronary revascularisation–10-year clinical outcomes of the prospective randomised study. Presenter: Mateusz Tajstra May 15, 2024 @TCTMD Follow Us
News Conference News EuroPCR 2024 Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT It’s not quite a stent and not quite a scaffold—either way, the device was associated with low rates of TLF over follow-up.
News Conference News EuroPCR 2024 Temporary Pacemaker After TAVI May Preclude Long-term Pacing Caitlin E. Cox May 24, 2024
News Conference News EuroPCR 2024 POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival Yael L. Maxwell May 22, 2024
News Conference News EuroPCR 2024 FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI Caitlin E. Cox May 20, 2024
News Conference News EuroPCR 2024 PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3 Yael L. Maxwell May 17, 2024
News Conference News EuroPCR 2024 OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO Caitlin E. Cox May 16, 2024
Presentation EuroPCR 2024 Small aortic annuli patients treated with TAVI: outcomes in women in the SMART trial Presenter: Roxana Mehran May 14, 2024
Presentation EuroPCR 2024 One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II Presenter: Ling Tao May 15, 2024
Presentation EuroPCR 2024 First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2 Presenter: Ole De Backer May 15, 2024
Presentation EuroPCR 2024 Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis Presenter: Frederik Zimmermann May 15, 2024
Presentation EuroPCR 2024 Hybrid coronary revascularisation–10-year clinical outcomes of the prospective randomised study. Presenter: Mateusz Tajstra May 15, 2024